- Free from Publisher JR Wood, EC Moreland, LK Volkening, BM … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—At pump start, patients (71% female) had a mean age of 14.1 ± 3.7
years, diabetes duration of 7.1 ± 4.0 years, daily blood glucose monitoring
(BGM) frequency of 4.0 ± 1.2, a daily insulin dose of 1.0 ± 0.3 units/kg, ... Cited by 23 - Related articles - BL Direct - All 5 versions
[CITATION] Nationwide improvement in HbA1c and complication screening in a benchmarking project in …
BP Ltd - Diabet. Med, 2007 - interscience.wiley.com Aims The German working group for pump therapy in paediatric patients has
defined seven indications for continuous subcutaneous insulin infusion (CSII):
dawn phenomenon, reduction of severe hypoglycaemia, improvement of ... Cited by 12 - Related articles - BL Direct - All 5 versions
R Nimri, N Weintrob, H Benzaquen, R Ofan, G … - Pediatrics, 2006 - Am Acad Pediatrics METHODS. The files of 279 patients who had type 1 diabetes and switched from
multiple daily injections to continuous subcutaneous insulin infusion between
1998 and 2003 were reviewed for glycemic control, body mass index standard ... Cited by 39 - Related articles - BL Direct - All 4 versions
R Hanas, P Adolfsson - Pediatric diabetes, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 37 - Related articles - BL Direct - All 3 versions
R Hanas, J Ludvigsson - Pediatric Diabetes, 2006 - interscience.wiley.com Abstract: This review deals with the two most serious side effects encountered
with insulin pump therapy, severe hypoglycemia and diabetic ketoacidosis (DKA).
Although clinical follow-up studies reported decreased rates of severe ... Cited by 31 - Related articles - BL Direct - All 3 versions
LA Fox, LM Buckloh, SD Smith, T Wysocki, N … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Eleven subjects from each group completed the trial (age 46.3 ± 3.2
months [means ± SE]). At baseline, there were no differences between groups in
HbA 1c , MBG, age, sex, diabetes duration, or parental QOL. Mean HbA 1c , ... Cited by 73 - Related articles - All 9 versions
R Hanas - Acta Biomed, 2005 - actabiomedica.it Although more than 40% of the participants in the intensive treatment group of
the Diabetes Control and Complications Trial (DCCT) employed insulin pumps, in
many countries the use of continuous sub- cutaneous insulin infusion (CSII) ... Cited by 5 - Related articles - View as HTML - All 3 versions
M Phillip, T Battelino, H Rodriguez, T Danne, … - Diabetes Care, 2007 - Am Diabetes Assoc Young patients with diabetes, their families, and their diabetes care providers
continue to be faced with the challenge of striving to maintain blood glucose
levels in the near-normal range. High blood glucose levels with elevated ... Cited by 44 - Related articles - BL Direct - All 7 versions
[CITATION] for the PedPump Group. A cross-sectional international survey of continuous subcutaneous …
